[1]
|
Weissleder R, Mahmood U. Molecular imaging(Review)[J]. Radiology, 2001, 219(2):316-333. |
[2]
|
Kang HW, Josephson L, Petrovsky A, et al. Magnetic resonance imaging of inducible E-selectin expression in human endothelial cell culture[J]. Bioconjug Chem, 2002,13(1):122-127. |
[3]
|
Schellenberger EA, Bogdanov A Jr, Hogemann D, et al. Annexin V-CLIO:A nanoparticle for detecting apopotosis by MRI[J]. Mol Imaging, 2002, 1(2):102-107. |
[4]
|
Silvio A, Walter D, Simonetta GC, et al. Innovative magnetic resonance imaging diagnostic agents based on paramagnetic Gd(Ⅲ)complexes[J]. Peptide Science, 2002, 66(6):419-428. |
[5]
|
Wiener EC, Konda S, Shadron A, et al. Targeting dendrimerchelates to tumors and tumor cells expressing the high-affinity folate receptor[J]. Invest Radiol, 1997, 32(12):748-754. |
[6]
|
Bhorade R,Weissleder R, Nokakoshi T, et al. Macrocyclic chelators with paramagnetic cations are internalized into mammalian cells via a HIV-tat derived membrane translocation peptide[J]. Bioconjugate Chem, 2000, 11(3):301-305. |
[7]
|
Bhujwalla ZM, Artemov D, Natarajan K, et al. Vascular diffrences detected by MRI for metastatic versus nonmetastatic breast and prostate cancer xenografts[J]. Neoplasia, 2001, 3(2):143-153. |
[8]
|
Artemov D, Mori N, Ravi R, et al. Magnetic resonance molecular imaging of the Her-2/neu receptor[J]. Cancer Res, 2003, 63(11):2723-2727. |
[9]
|
Bogdanov A Jr, Matuszewski L, Bremer C, et al. Oligomerization of paramagnetic substrates result in signal amplification and can be used for MR imaging of molecular targets[J]. Mol Imaging, 2002, 1(1):16-23. |
[10]
|
Li KC, Bednarski MD. Vascular targeted molecular imaging using functionalized polymerized vesicles[J]. J Magn Reson Imaging,2002, 16(4):388-393. |
[11]
|
Turetschek K, Preda A, Floyd E, et al. MRI monitoring of tumor response following angiogenesis inhibition in an experimental human breast cancer model[J]. Eur J Nucl Med Mol Imaging, 2003,30(3):448-455. |
[12]
|
Kurhanewicz J, Mark GS, Nelson SJ, et al. Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer[J]. J Magnet Resonance Imaging, 2002,16(4):451-463. |
[13]
|
Tzika AA, Loukas GA, Zarifi MK, et al. Spectroscopic and perfusion magnetic resonance imaging predictors of progression in pediatric brain tumors[J]. Cancer, 2004, 100(6):1246-1256. |
[14]
|
Alfke H, Stoppler H, Nocken F, et al. In vitro MR imaging of regulated gene expression[J]. Radiology, 2003, 228(2):488-492. |
[15]
|
Bogdanov A Jr, Weissleder R. The development of in vivo imaging systems to study gene expression[J]. Trends Biotechnol, 1998, 16(1):5-10. |
[16]
|
Weissleder R, Moore A, Mahmood U, et al. In vivo magnetic resonance imaging of transgene expression[J]. Nat Med, 2000, 6(3):351-355. |
[17]
|
Iehikawa T, Hogemann D, Saeki Y, et al. MRI of transgene expression:correlation to therapeutic gene expression[J]. Neoplasia, 2002,4(6):523-530. |
[18]
|
Heckl S, Pipkorn R, Waldeck W, et al. Intracellular visualization of prostate cancer using magnetic resonance imaging[J]. Cancer Res,2003, 63(16):4766-4772. |